Sectoral Asset Management Inc Clovis Oncology, Inc. Transaction History

Sectoral Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$11.63 - $32.67 $5.16 Million - $14.5 Million	-443,397 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $2.19 Million - $3.7 Million	74,698 Added 20.26%	443,397 $13 Million
Q2 2018 Aug 13, 2018	BUY	$42.06 - $62.4 $2.01 Million - $2.99 Million	47,900 Added 14.93%	368,699 $16.8 Million
Q1 2018 May 15, 2018	BUY	$50.12 - $67.72 $6.93 Million - $9.36 Million	138,199 Added 75.68%	320,799 $16.9 Million
Q4 2017 Feb 13, 2018	SELL	$57.69 - $84.58 $3.99 Million - $5.84 Million	-69,099 Reduced 27.45%	182,600 $12.4 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $16.9 Million - $21.3 Million	251,699	251,699 $20.7 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.